
Monday, May 12, 2025 9:21:22 AM
I don't think I have actually argued any *actual* facts you have posted. The dilution sucks. I don't like it, no one does.
The only thing I argue is the way you twist things, lie, and are disingenuous. You try to represent there is no growth in sales or revenue. You say that every dollar is wasted in R&D. You continually shit talk every aspect of the company even when there are CLEAR successes or improvements. You disparage the employees saying they do nothing all day. You say no one is using the product even as sales have grown. Every deployed unit (not sure if RMR or SALE) you claim is a free unit, even though revenue goes up.
You also try to misrepresent what individuals say. You'll probably open the response to this comment by trying to assign some emotion to others like you normally do (Why are you mad? Are you feelings hurt?). This will be followed by anywhere from 1-5 posts trying to gish gallop the person you respond to and the board in general.
😅

Recent AITX News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:57:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 10:01:43 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/26/2025 04:15:20 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/20/2025 01:31:10 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/18/2025 06:41:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 10:01:54 AM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/17/2025 09:03:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 09:00:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 02:02:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 08:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 10:02:52 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/06/2025 08:55:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 10:01:55 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/03/2025 09:19:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 10:02:44 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/29/2025 09:26:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2025 07:59:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 10:01:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 10:01:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 10:01:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 10:04:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 10:01:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 10:06:05 AM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM